News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ensemble Therapeutics Corporation Extends Macrocycle Drug Discovery Alliance with Bristol-Myers Squibb Company (BMY)



1/5/2012 6:53:46 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ensemble Therapeutics, a biotechnology company developing EnsemblinsTM, a novel class of small molecule therapeutics with the power of biologics, announced today the extension of its strategic alliance with Bristol-Myers Squibb (NYSE: BMS), building on a collaboration initiated in April 2009.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES